UH President Renu Khator (right) and Principal, Vice-Chancellor and Professor of HWU Richard A. Williams signed the memorandum earlier this month. Photo via UH.edu

The University of Houston and Heriot-Watt University in Scotland signed a memorandum of understanding earlier this month that celebrates an official partnership between the schools in education, research, and innovation for the energy transition.

The universities will particularly focus on hydrogen energy solutions, according to a statement from UH.

"I am thrilled to witness the official celebration of our shared commitment to advancing transformative energy solutions,” Ramanan Krishnamoorti, vice president for energy and innovation at UH, says in a statement. “Through this partnership, we aim to harness our collective expertise to address pressing energy challenges and drive sustainable innovation on a global scale."

UH President Renu Khator and Principal, Vice-Chancellor and Professor of HWU Richard A. Williams signed the memorandum on April 11. Faculty members from UH and HWU then held a two-day technology workshop in Houston where the teams discussed areas of collaboration and future projects.

Through the partnership, the schools aim to offer more opportunities for students and faculty via interdisciplinary research, student exchange programs, joint degree offerings and industry partnerships around the world. HWU, for instance, has five campuses throughout Scotland, the UAE and Malaysia.

“This agreement represents a pivotal milestone in the international development of our global research institutes, forging a new partnership to address the most pressing societal challenges that lie ahead,” Gillian Murray, deputy principal of business and enterprise at HWU who attended the signing, adds in the statement.

Houston has been a hub for notable partnerships focused on the energy transition in recent months.

The Greater Houston Partnership and the Houston Energy Transition Initiative announced last month during CERAWeek that they had signed a memorandum of understanding with Argonne National Laboratory, a federally-funded research and development facility in Illinois owned by the United States Department of Energy and run by UChicago Argonne LLC of the University of Chicago.

The partnership aims to spur the development of commercial-scale energy transition solutions.

------

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.